Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Bone Marrow Transplantation
|
March 30, 2001
Mesenchymal stem cells: heading into the clinic
O N Koç, H M Lazarus
Bone Marrow Transplantation
|
November 18, 2000
Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation
J Friedman, H M Lazarus, O N Koç
Journal of Hematotherapy & Stem Cell Research
|
May 3, 2000
Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction
J S Reese, O N Koç, S L Gerson
Blood
|
May 16, 2000
Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection
B M Davis, O N Koç, S L Gerson
Journal of Hematotherapy & Stem Cell Research
|
October 24, 2001
G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O6-benzylguanine and BCNU
K Lee, S L Gerson, B Maitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1996
Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors
J A Allay, O N Koç, B M Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells
L Liu, K Lee, J Schupp, et al.
Cancer Gene Therapy
|
July 27, 1999
Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer
O N Koç, J S Reese, E M Szekely, et al.
Progress in Experimental Tumor Research
|
July 1, 1999
O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents
B M Davis, O N Koç, J S Reese, et al.
Bone Marrow Transplantation
|
August 31, 2002
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
O N Koç, J Day, M Nieder, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Bone Marrow Transplantation
|
March 30, 2001
Mesenchymal stem cells: heading into the clinic
O N Koç, H M Lazarus
Bone Marrow Transplantation
|
November 18, 2000
Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation
J Friedman, H M Lazarus, O N Koç
Journal of Hematotherapy & Stem Cell Research
|
May 3, 2000
Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction
J S Reese, O N Koç, S L Gerson
Blood
|
May 16, 2000
Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection
B M Davis, O N Koç, S L Gerson
Journal of Hematotherapy & Stem Cell Research
|
October 24, 2001
G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O6-benzylguanine and BCNU
K Lee, S L Gerson, B Maitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1996
Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors
J A Allay, O N Koç, B M Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells
L Liu, K Lee, J Schupp, et al.
Cancer Gene Therapy
|
July 27, 1999
Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer
O N Koç, J S Reese, E M Szekely, et al.
Progress in Experimental Tumor Research
|
July 1, 1999
O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents
B M Davis, O N Koç, J S Reese, et al.
Bone Marrow Transplantation
|
August 31, 2002
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
O N Koç, J Day, M Nieder, et al.
Page
of 3